-
1 Comment
Shenzhen Neptunus Interlong Bio-technique Company Limited is currently in a long term downtrend where the price is trading 17.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Shenzhen Neptunus Interlong Bio-technique Company Limited's total revenue sank by 14.3% to $272M since the same quarter in the previous year.
Its net income has dropped by 65.6% to $8M since the same quarter in the previous year.
Finally, its free cash flow grew by 163.5% to $71M since the same quarter in the previous year.
Based on the above factors, Shenzhen Neptunus Interlong Bio-technique Company Limited gets an overall score of 2/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | CNE100000775 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | -0.09 |
|---|---|
| Market Cap | 487M |
| PE Ratio | 14.5 |
| Target Price | None |
| Dividend Yield | None |
Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People's Republic of China. It offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. The company is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. The company was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8329.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
